Prevention of Early Sudden Circulatory Collapse After the Norwood Operation

Background—After modifications in our perioperative management protocol, we have observed a decrease in sudden circulatory collapse after the Norwood operation. The current study examines early outcomes after the Norwood operation in our unit in an attempt to identify variables that may have altered the risk of unexpected circulatory collapse. Methods and Results—We studied 105 consecutive neonates who underwent a Norwood operation in our institution. Our treatment protocol has changed in the past 3 years to include the use of alpha-blockade with phenoxybenzamine (POB) for systemic afterload reduction and selective cerebral perfusion. Forty-eight infants had selective cerebral perfusion. Forty-two infants received POB. Sixty patients had hypoplastic left heart syndrome. There was no difference in age, diagnosis, number of neonates with weight <2.5 kg, aortic size diameter <2 mm, highest preoperative lactate level, and shunt size indexed to body weight among patients with or without use of POB. Twenty-five infants had circulatory collapse during the first 72 hours. Twelve of them could be explained by technical issues. Thirteen others who appeared clinically stable had early sudden circulatory collapse without an apparent cause. Sixteen out of 25 neonates died. Of those with technical problems, 8 out of 12 died. Based on the hazard function, 3 incremental risk factors for early circulatory collapse were technical issue at operation (P<0.001), longer cross-clamp time (P<0.007), and no use of POB (P<0.002). For a technically successful operation, freedom from circulatory collapse at 72 hours is 95% with the use of POB versus 69% without (P<0.002). Diagnosis, aortic size, atrioventricular valve function, birth weight, age at operation, and total circulatory arrest time and were not predictive of early sudden circulatory collapse. Conclusion—Recent changes in our treatment protocol have resulted in a decrease incidence of sudden circulatory collapse after the Norwood operation. Optimal surgical technique is the most important predictor of early survival. The use of aggressive afterload reduction with POB reduced the risk of early sudden arrest.

[1]  Eugene H Blackstone,et al.  Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. , 2003, The Journal of thoracic and cardiovascular surgery.

[2]  S. Berger,et al.  Improved Survival of Patients Undergoing Palliation of Hypoplastic Left Heart Syndrome: Lessons Learned From 115 Consecutive Patients , 2002, Circulation.

[3]  I. Konstantinov,et al.  Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure. , 2002, The Journal of thoracic and cardiovascular surgery.

[4]  W. Williams,et al.  Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience. , 2001, The Annals of thoracic surgery.

[5]  S M Schwartz,et al.  Unrecognized Pulmonary Venous Desaturation Early After Norwood Palliation Confounds ˙Qp:˙Qs Assessment and Compromises Oxygen Delivery , 2001, Circulation.

[6]  B. Clark,et al.  Survival After Reconstructive Surgery for Hypoplastic Left Heart Syndrome: A 15-Year Experience From a Single Institution , 2000, Circulation.

[7]  N. Poirier,et al.  Modified Norwood procedure with a high-flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction. , 2000, The Journal of thoracic and cardiovascular surgery.

[8]  C. Goldberg,et al.  Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. , 2000, The Journal of thoracic and cardiovascular surgery.

[9]  B. Griffith,et al.  Regional low-flow perfusion provides cerebral circulatory support during neonatal aortic arch reconstruction. , 2000, The Journal of thoracic and cardiovascular surgery.

[10]  U Bartram,et al.  Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. , 1997, The Annals of thoracic surgery.

[11]  R. Caldwell,et al.  Surgical management of hypoplastic left heart syndrome. , 1996, The Annals of thoracic surgery.

[12]  J. Mayer,et al.  Ten-year institutional experience with palliative surgery for hypoplastic left heart syndrome. Risk factors related to stage I mortality. , 1995, Circulation.

[13]  Randall B. Griepp,et al.  Usefulness of intermittent monitoring of mixed venous oxygen saturation after stage I palliation for hypoplastic left heart syndrome. , 1994, The American journal of cardiology.

[14]  M. Iannettoni,et al.  Improving results with first-stage palliation for hypoplastic left heart syndrome. , 1994, The Journal of thoracic and cardiovascular surgery.

[15]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .

[16]  W. Norwood,et al.  Physiologic repair of aortic atresia-hypoplastic left heart syndrome. , 1983, The New England journal of medicine.

[17]  J. Schrader,et al.  The Working Heart , 2005 .

[18]  G. V. van Arsdell,et al.  Practical use of alpha blockade strategy in the management of hypoplastic left heart syndrome following stage one palliation with a Blalock-Taussig shunt. , 2004, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[19]  G. V. Arsdell,et al.  Practical use of alpha blockade strategy in the management of hypoplastic left heart syndrome following stage one palliation with a Blalock-Taussig shunt. , 2004 .

[20]  T. Hori,et al.  Suitable shunt size for regulation of pulmonary blood flow in a canine model of univentricular parallel circulations. , 2003, The Journal of thoracic and cardiovascular surgery.

[21]  J. P. Thomas,et al.  Phenoxybenzamine improves systemic oxygen delivery after the Norwood procedure. , 1999, The Annals of thoracic surgery.

[22]  A. Katz Physiology of the heart , 1977 .